Vericel (VCEL)
(Delayed Data from NSDQ)
$35.63 USD
+0.69 (1.97%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $35.64 +0.01 (0.03%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Vericel Corporation has a market cap of $1.76B, which represents its share price of $34.94 multiplied by its outstanding shares number of 50.34M. As a small-cap company, VCEL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
VCEL 35.63 +0.69(1.97%)
Will VCEL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VCEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VCEL
Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
VCEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates
Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates
Travere Therapeutics (TVTX) Reports Q1 Loss, Tops Revenue Estimates
Other News for VCEL
Vericel (VCEL) Price Target Reduced Despite Solid Earnings
Vericel price target lowered by $3 at Canaccord, here's why
Canaccord Genuity Lowers Price Target on Vericel (VCEL) but Maintains 'Buy' Rating | VCEL Stock News
Vericel Corp (VCEL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight